⌘K

Vincerx Pharma, Inc. (VINC)

$0.70 1.67% $0.01 Healthcare

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.

Market cap

$21.59M

CEO

Dr. Ahmed M. Hamdy M.D.

Full time employees

56.00

Headquarters

Palo Alto, CA

IPO Date

May 27, 2020

Price-to-earnings (PE) Ratio

-0.61

Earnings-per-share (EPS)

$-1.14

Cash ratio (TTM)

0.73

Current ratio (TTM)

3.47

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-0.30

Price-to-book ratio (TTM)

0.59

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

3.14

Return on assets (TTM)

-133.38%

Return on equity (TTM)

-113.39%

Similar stocks (16)

Applied Therapeutics, Inc.

APLT

$8.00 1.91% $0.15

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.13 7.62% $0.08

Downtrend

BioAtla, Inc.

BCAB

$1.74 4.82% $0.08

Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12% $0.02

Downtrend

Protara Therapeutics, Inc.

TARA

$1.97 2.60% $0.05

Downtrend

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.63 1.35% $0.00

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21% $0.56

Neutral

Senti Biosciences, Inc.

SNTI

$3.13 1.38% $0.04

Downtrend

Vaccinex, Inc.

VCNX

$4.55 -11.99% $-0.62

Downtrend

Fresh Tracks Therapeutics, Inc.

FRTX

$0.78 4.70% $0.04

Downtrend

Processa Pharmaceuticals, Inc.

PCSA

$1.37 -3.52% $-0.05

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.16 10.00% $0.02

Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (16)

Applied Therapeutics, Inc.

APLT

$8.00 1.91% $0.15

Uptrend

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Shattuck Labs, Inc.

STTK

$3.70 1.37% $0.05

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.13 7.62% $0.08

Downtrend

BioAtla, Inc.

BCAB

$1.74 4.82% $0.08

Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12% $0.02

Downtrend

Protara Therapeutics, Inc.

TARA

$1.97 2.60% $0.05

Downtrend

Surrozen, Inc.

SRZN

$8.15 1.75% $0.14

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.63 1.35% $0.00

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.67% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.50 14.21% $0.56

Neutral

Senti Biosciences, Inc.

SNTI

$3.13 1.38% $0.04

Downtrend

Vaccinex, Inc.

VCNX

$4.55 -11.99% $-0.62

Downtrend

Fresh Tracks Therapeutics, Inc.

FRTX

$0.78 4.70% $0.04

Downtrend

Processa Pharmaceuticals, Inc.

PCSA

$1.37 -3.52% $-0.05

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.16 10.00% $0.02

Downtrend

ETF Exposure (5)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$282.05 1.69% $4.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend